# AtaCor Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/atacor-medical

- Industry: Medical Devices & Equipment
- Headquarters: San Clemente, US
- Website: www.atacor.com/
- Total disclosed funding: $55M
- Latest round: Series C (Apr 24, 2024)
- Investors on record: 7

## About

Founded in 2014 and based in California, US, AtaCor Medical, Inc. operates as a developer of temporary, interim, and permanent cardiac implantable pacing systems that help monitor cardiac rhythm. In October 2025, AtaCor Medical, Inc. raised USD 75 million in venture funding from unspecified investors.

The company's flagship products include the AtaCor EV Temporary Pacing System and the AtaCor EV-ICD Lead System. The EV Temporary Pacing System provides a novel method for temporary cardiac pacing without entering the heart or vascular system, thereby reducing risks and enhancing patient comfort. Similarly, the EV-ICD Lead System is designed for extravascular defibrillation, offering a streamlined, less invasive alternative to traditional transvenous and subcutaneous ICDs. Both systems aim to improve patient outcomes by minimizing procedural complications and discomfort.

AtaCor’s revenue model will center on medical device sales to hospitals and cardiac care centers, complemented by training and support services. Future streams may include licensing of proprietary deployment technologies and strategic partnerships with ICD manufacturers.

AtaCor Medical plans to utilize the October 2025 funding to support its U.S. FDA Pivotal Study evaluating the EV-ICD system for treating ventricular tachyarrhythmias.

## Funding rounds

- Series C, Apr 24, 2024, $21M — Hatteras Venture Partners, Arboretum Ventures, Catalyst Health Ventures, Broadview Ventures, BayMed Venture Partners
- Series B, Apr 28, 2020, $25M — Hatteras Venture Partners, Catalyst Health Ventures, Broadview Ventures, aMoon, Longview Ventures
- Series A, Sep 18, 2018, $9M — Broadview Ventures, aMoon

## Investors

- Broadview Ventures (https://capitalatlas.ai/funds/broadview-ventures) — Series A, Series B, Series C
- aMoon (https://capitalatlas.ai/funds/amoon) — Series A, Series B
- Hatteras Venture Partners (https://capitalatlas.ai/funds/hatteras-venture-partners) — Series B, Series C
- Catalyst Health Ventures (https://capitalatlas.ai/funds/catalyst-health-ventures) — Series B, Series C
- Longview Ventures — Series B
- Arboretum Ventures (https://capitalatlas.ai/funds/arboretum-ventures) — Series C
- BayMed Venture Partners (https://capitalatlas.ai/funds/baymed-venture-partners) — Series C